1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
FEATURED COMPANIES
- EMIS Group plc
- Smith & Nephew Plc
- Source BioScience Ltd
1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
Summary
Immunodiagnostic Systems Holdings plc (IDS) is an in-vitro diagnostic solution provider that develops, manufactures and markets immunoassays and automated immunoanalyser technologies. The company conducts research in the areas of bone turnover market, animal research, and other research areas. IDS clinical areas include bone metabolism, calcium metabolism, chronic kidney disease and mineral bone disorders, fertility, growth disorders, and cartilage markers. The company offers IDS-iSYS multi-discipline automated system, an instrument based on chemiluminescence and absorbency technology to improve productivity and efficiency of specialty immunoassay testing in laboratories of all types and volumes.IDS offers application training and advice, customized training, qualified customer care centers and regionalised proximity teams. The company has operations in the UK, Italy, Australia, Japan, Germany, France, Norway, Belgium and the US. IDS is headquartered in Tyne and Wear, the UK.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
Reasons to Buy:
Note: Some sections may be missing if data is unavailable for the company
Immunodiagnostic Systems Holdings plc (IDS) is an in-vitro diagnostic solution provider that develops, manufactures and markets immunoassays and automated immunoanalyser technologies. The company conducts research in the areas of bone turnover market, animal research, and other research areas. IDS clinical areas include bone metabolism, calcium metabolism, chronic kidney disease and mineral bone disorders, fertility, growth disorders, and cartilage markers. The company offers IDS-iSYS multi-discipline automated system, an instrument based on chemiluminescence and absorbency technology to improve productivity and efficiency of specialty immunoassay testing in laboratories of all types and volumes.IDS offers application training and advice, customized training, qualified customer care centers and regionalised proximity teams. The company has operations in the UK, Italy, Australia, Japan, Germany, France, Norway, Belgium and the US. IDS is headquartered in Tyne and Wear, the UK.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Immunodiagnostic Systems Holdings Plc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- EMIS Group plc
- Smith & Nephew Plc
- Source BioScience Ltd
Immunodiagnostic Systems Holdings Plc Company Overview
Immunodiagnostic Systems Holdings Plc - Pipeline Analysis Overview
Immunodiagnostic Systems Holdings Plc Pipeline Products Overview
Immunodiagnostic Systems Holdings Plc - Key Competitors
Head Office
Recent Developments
Appendix
List of Tables
List of Figures
Note: Product cover images may vary from those shown
A selection of companies mentioned in this report includes:
- Source BioScience Ltd
- EMIS Group plc
- Smith & Nephew Plc
Note: Product cover images may vary from those shown